Philips recently showcased its latest innovations in radiation therapy at the ASTRO 2025 Annual Meeting. The company introduced the Philips Rembra RT and Philips Areta RT CT platforms, which aim to enhance precision in cancer care. These advancements are designed to improve accuracy and efficiency in radiation therapy, addressing the increasing complexities of treatment planning. Citigroup maintains a Neutral rating for Philips (NYSE:PHG), with a raised price target, indicating cautious optimism. Philips in ...